Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Treilleux

Showing results (111-120 of 186) with videos related to

Pageof 19
Sort By:
The Journal of Pathology|December 3, 2021
Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanismVictoria Cluzet, Marie M Devillers, Florence Petit, et al.
Scientific Reports|November 3, 2020
Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypesSolene De Talhouet, Julien Peron, Aurelie Vuilleumier, et al.
Stem Cell Reports|January 21, 2015
Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell responseMarion Chapellier, Elodie Bachelard-Cascales, Xenia Schmidt, et al.
Translational Oncology|October 3, 2020
Combined proteomic and transcriptomic approaches reveal externalized keratin 8 as a potential therapeutic target involved in invasiveness of head and neck cancersMarie Alexandra Albaret, Arnaud Paré, Lucie Malet, et al.
Bulletin Du Cancer|March 30, 2012
Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees' organizationPatrick Castel, Louis Tassy, Antoine Lurkin, et al.
The Journal of Pathology|February 17, 2017
The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the boneAurélie Bellanger, Caterina F Donini, Julie A Vendrell, et al.
Therapeutic Advances in Medical Oncology|August 11, 2025
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacyOlivia Le Saux, Renaud Sabatier, Isabelle Treilleux, et al.
Journal for Immunotherapy of Cancer|November 8, 2023
MDR1-EXPRESSING CD4<sup>+</sup> T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSEAnthony Di Roio, Margaux Hubert, Laurie Besson, et al.
Plos One|May 12, 2011
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patientsDaniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Primary Vulvar and Vaginal Adenocarcinomas of Intestinal Type Are Closer To Colorectal Adenocarcinomas Than To Carcinomas of Müllerian OriginAlexis Trecourt, Isabelle Treilleux, Daniel Pissaloux, et al.
Pageof 19

Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
The Journal of Pathology|December 3, 2021
Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanismVictoria Cluzet, Marie M Devillers, Florence Petit, et al.
Scientific Reports|November 3, 2020
Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypesSolene De Talhouet, Julien Peron, Aurelie Vuilleumier, et al.
Stem Cell Reports|January 21, 2015
Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell responseMarion Chapellier, Elodie Bachelard-Cascales, Xenia Schmidt, et al.
Translational Oncology|October 3, 2020
Combined proteomic and transcriptomic approaches reveal externalized keratin 8 as a potential therapeutic target involved in invasiveness of head and neck cancersMarie Alexandra Albaret, Arnaud Paré, Lucie Malet, et al.
Bulletin Du Cancer|March 30, 2012
Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees' organizationPatrick Castel, Louis Tassy, Antoine Lurkin, et al.
The Journal of Pathology|February 17, 2017
The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the boneAurélie Bellanger, Caterina F Donini, Julie A Vendrell, et al.
Therapeutic Advances in Medical Oncology|August 11, 2025
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacyOlivia Le Saux, Renaud Sabatier, Isabelle Treilleux, et al.
Journal for Immunotherapy of Cancer|November 8, 2023
MDR1-EXPRESSING CD4<sup>+</sup> T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSEAnthony Di Roio, Margaux Hubert, Laurie Besson, et al.
Plos One|May 12, 2011
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patientsDaniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Primary Vulvar and Vaginal Adenocarcinomas of Intestinal Type Are Closer To Colorectal Adenocarcinomas Than To Carcinomas of Müllerian OriginAlexis Trecourt, Isabelle Treilleux, Daniel Pissaloux, et al.
Pageof 19